Biologics and Biosimilars

Biologics and Biosimilars focuses on the development, regulation, and therapeutic application of complex biological products and their biosimilar counterparts. This track will explore advances in monoclonal antibodies, recombinant proteins, and cell-based therapies, along with the challenges of biosimilar development, comparability studies, and regulatory approval pathways. Discussions will emphasize the clinical impact, safety, efficacy, and cost-effectiveness of biologics and biosimilars in treating chronic and life-threatening conditions, enhancing access to innovative healthcare solutions globally.

 

    Related Conference of Biologics and Biosimilars

    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France

    Biologics and Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in